SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 65 filers reported holding SUTRO BIOPHARMA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,277,712 | +53.9% | 281,895 | +5.7% | 0.92% | +91.9% |
| Q3 2022 | $1,480,000 | -20.5% | 266,679 | -25.4% | 0.48% | -26.2% |
| Q2 2022 | $1,862,000 | -23.6% | 357,465 | +20.6% | 0.65% | +1.7% |
| Q1 2022 | $2,437,000 | +46.5% | 296,508 | +165.2% | 0.64% | +59.7% |
| Q4 2021 | $1,664,000 | -55.4% | 111,803 | -35.0% | 0.40% | -70.2% |
| Q4 2020 | $3,735,000 | -19.6% | 172,047 | -62.8% | 1.35% | -2.0% |
| Q3 2020 | $4,645,000 | +283.6% | 462,170 | +196.3% | 1.37% | +1981.8% |
| Q2 2020 | $1,211,000 | +237.3% | 156,005 | +377.6% | 0.07% | -41.6% |
| Q4 2019 | $359,000 | – | 32,666 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |